Publication:
The impact of wild-type reversion on transmitted resistance surveillance

Simple item page
dc.contributor.authorDavid C. Boettigeren_US
dc.contributor.authorSasisopin Kiertiburanakulen_US
dc.contributor.authorSomnuek Sungkanuparphen_US
dc.contributor.authorMatthew G. Lawen_US
dc.contributor.otherUniversity of New South Wales (UNSW) Australiaen_US
dc.contributor.otherMahidol Universityen_US
dc.date.accessioned2018-11-09T02:58:40Z
dc.date.available2018-11-09T02:58:40Z
dc.date.issued2014-01-01en_US
dc.identifier.citationAntiviral Therapy. Vol.19, No.7 (2014), 719-722en_US
dc.identifier.doi10.3851/IMP2746en_US
dc.identifier.issn20402058en_US
dc.identifier.issn13596535en_US
dc.identifier.other2-s2.0-84920174128en_US
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/20.500.14594/34733
dc.rightsMahidol Universityen_US
dc.rights.holderSCOPUSen_US
dc.source.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84920174128&origin=inwarden_US
dc.subjectMedicineen_US
dc.subjectPharmacology, Toxicology and Pharmaceuticsen_US
dc.titleThe impact of wild-type reversion on transmitted resistance surveillanceen_US
dc.typeLetteren_US
dspace.entity.typePublication
mu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84920174128&origin=inwarden_US

Files

Collections

Scopus 2011-2015